Washington, DC 20549



FORM 12b-25





S Form 10-K £ Form 20-F £ Form 11-K £ Form 10-Q £ Form 10-D £ Form N-SAR


For the Period Ended: December 31, 2011


£ Transition Report on Form 10-K

£ Transition Report on Form 20-F

£ Transition Report on Form 11-K

£ Transition Report on Form 10-Q

£ Transition Report on Form N-SAR


For the Transition Period Ended:


Read Instruction

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:







Neuralstem, Inc.

Full Name of Company:



Former Name, if Applicable:


9700 Great Seneca Highway

Address of Principal Executive Office (Street and Number):


Rockville, Maryland 20850

City, State and Zip Code



PART II - RULES 12b-25 (b) and (c)


If the subject report could not be filed without reasonable effort or expense and the Company seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)


S (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
S (b) The subject annual report or semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
£ (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable)






Documentation necessary in order to prepare a complete filing could not have been obtained without unreasonable effort or expense. The Company expects to file within the extension period.




 (1)Name and telephone number of person to contact in regard to this notification:
  Richard Garr 301-366-4841
(2)Have all or other periodic report required under section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company act of 1940 during the preceding 12 months or for such shorter period that the Company was required to file such report(s) been filed? If the answer is no, identify report(s).

S Yes £ No




(3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

£ Yes S No


If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.





Neuralstem, Inc. has caused this notification to be signed on its behalf by the undersigned, thereunto duly authorized.



Date   March 15, 2012   By:  /s/I. Richard Garr  
    Chief Executive Officer